← Leaderboards
Troy R Torgerson
Baylor College Of Medicine
$5,841,511
Attributed
$12,879,063
Total exposure
15
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.9M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,179,063 · 16
By mechanism
U19$8,400,000 · 7
R24$3,580,422 · 1
U24$2,115,359 · 1
UH3$1,700,517 · 1
UG3$1,217,582 · 1
P01$1,009,942 · 1
Top collaborators
- Margaret Juliana Mcelrath9 shared
- Kenneth D Stuart9 shared
- Ivan Kingyue Chinn4 shared
- Lisa Forbes4 shared
- Christopher Craig Dvorak3 shared
- Elie Haddad3 shared
- Rebecca Marsh3 shared
- Michael Wagner3 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Amit Joshi$4,022,481
- David B. Roth$10,563,237
- Stephen Gottschalk$13,145,706
- Arthur L. Beaudet$51,053,980
- Robert T Dirksen$17,610,202
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneGenesMolecularImmunologic Deficiency SyndromesAffectMutationCongenital ImmunodeficiencyCellsBone Marrow TransplantationLinkImmunologyBaseImmune SystemPhenotypeInfectionImmunologistPredispositionResponseImmune System DiseasesDiagnosisImmune ResponseT-LymphocyteDefectLead
Grant awards (36)
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization$2,100,000
U19 · FY2025 · AI
Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity$1,743,065
R24 · FY2025 · AI
Curation of genetic defects causing combined immunodeficiency and infections in children$1,047,682
U24 · FY2025 · HD
Core-002$971,739
U19 · FY2025 · AI
Safety and Efficacy of Itacitinib in treatment of JAK/STAT pathway disorders with activating mutations$857,021
UH3 · FY2025 · TR
Project-004$364,996
U19 · FY2025 · AI
Core-001$309,424
U19 · FY2025 · AI
Project-002$160,656
U19 · FY2025 · AI
Admin-Core-001$153,526
U19 · FY2025 · AI
Project-003$139,659
U19 · FY2025 · AI
Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity$21,475
R24 · FY2025 · AI
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization$2,100,000
U19 · FY2024 · AI
Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity$1,815,882
R24 · FY2024 · AI
Safety and Efficacy of Itacitinib in treatment of JAK/STAT pathway disorders with activating mutations$843,496
UH3 · FY2024 · TR
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization$2,100,000
U19 · FY2023 · AI
Curation of genetic defects causing combined immunodeficiency and infections in children$344,400
U24 · FY2023 · HD
Primary Immune Regulatory Disorders: Clinical Presentations, Treatments and Outcomes$63,934
U54 · FY2023 · AI · contact PI
Safety and Efficacy of Itacitinib in treatment of JAK/STAT pathway disorders with activating mutations$569,965
UG3 · FY2022 · TR
Curation of genetic defects causing combined immunodeficiency and infections in children$350,956
U24 · FY2022 · HD
Safety and Efficacy of Itacitinib in treatment of JAK/STAT pathway disorders with activating mutations$647,617
UG3 · FY2021 · TR
Curation of genetic defects causing combined immunodeficiency and infections in children$372,321
U24 · FY2021 · HD
Primary Immune Regulatory Disorders: Clinical Presentations, Treatments and Outcomes$56,235
U54 · FY2021 · AI · contact PI
Primary Immune Regulatory Disorders: Clinical Presentations, Treatments and Outcomes$57,878
U54 · FY2020 · AI · contact PI
Primary Immune Regulatory Disorders: Clinical Presentations, Treatments and Outcomes$77,183
U54 · FY2019 · AI · contact PI
Immune Function Studies$176,689
P01 · FY2016 · AI · contact PI
Immune Function Studies$176,477
P01 · FY2015 · AI · contact PI
Immune Function Studies$299,290
P01 · FY2014 · AI · contact PI
GLILD in CVID$279,802
R34 · FY2014 · AI
Immune Function Studies$166,395
P01 · FY2013 · AI · contact PI
Immune Function Studies$191,091
P01 · FY2012 · AI · contact PI
Characterization of Immune Deficiency in Congenital Bone Marrow Failure Syndromes$107,045
R03 · FY2012 · AI · contact PI
Characterization of Immune Deficiency in Congenital Bone Marrow Failure Syndromes$106,617
R03 · FY2011 · AI · contact PI
FOXP3 Structure, Function and Regulatory Activity in T cells$119,340
K08 · FY2009 · AI · contact PI
FOXP3 Structure, Function and Regulatory Activity in T cells$48,527
K08 · FY2009 · AI · contact PI
FOXP3 Structure, Function and Regulatory Activity in T cells$119,340
K08 · FY2008 · AI · contact PI
FOXP3 Structure, Function and Regulatory Activity in T cells$119,340
K08 · FY2007 · AI · contact PI